1 Day RHHBY 2.56% DJIA 0.77% S&P 500 1.04% Health Care/Life Sciences 0.10% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Make space on your beauty counter! Here’s our expert-approved list of the best makeup, skincare and haircare dupes in the ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...

A couple of weeks ago, we tested the Sony A6600, which is the company's latest flagship APS-C mirrorless camera. Now, it's time to take a closer look at the A6100, which is its entry-level sibling.

At close: February 5 at 5:35:39 PM GMT+1 ...